LGND·53220K504·US·equity·Healthcare - Biotechnology-13D/G
LGND (LIGAND PHARMACEUTICALS INC) is held by 159 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($591.3M), JANUS HENDERSON GROUP PLC ($201.6M), Invesco Ltd. ($164.4M). Net institutional sentiment: Mixed.
See how LGND's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer